Triflupromazine

Jump to: navigation, search
Triflupromazine
Triflupromazine.png
Triflupromazine0.png
Clinical data
AHFS/Drugs.comMicromedex Detailed Consumer Information
MedlinePlusa600010
ATC code
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC18H19F3N2S
Molar mass352.418 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Triflupromazine

Articles

Most recent articles on Triflupromazine

Most cited articles on Triflupromazine

Review articles on Triflupromazine

Articles on Triflupromazine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Triflupromazine

Images of Triflupromazine

Photos of Triflupromazine

Podcasts & MP3s on Triflupromazine

Videos on Triflupromazine

Evidence Based Medicine

Cochrane Collaboration on Triflupromazine

Bandolier on Triflupromazine

TRIP on Triflupromazine

Clinical Trials

Ongoing Trials on Triflupromazine at Clinical Trials.gov

Trial results on Triflupromazine

Clinical Trials on Triflupromazine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Triflupromazine

NICE Guidance on Triflupromazine

NHS PRODIGY Guidance

FDA on Triflupromazine

CDC on Triflupromazine

Books

Books on Triflupromazine

News

Triflupromazine in the news

Be alerted to news on Triflupromazine

News trends on Triflupromazine

Commentary

Blogs on Triflupromazine

Definitions

Definitions of Triflupromazine

Patient Resources / Community

Patient resources on Triflupromazine

Discussion groups on Triflupromazine

Patient Handouts on Triflupromazine

Directions to Hospitals Treating Triflupromazine

Risk calculators and risk factors for Triflupromazine

Healthcare Provider Resources

Symptoms of Triflupromazine

Causes & Risk Factors for Triflupromazine

Diagnostic studies for Triflupromazine

Treatment of Triflupromazine

Continuing Medical Education (CME)

CME Programs on Triflupromazine

International

Triflupromazine en Espanol

Triflupromazine en Francais

Business

Triflupromazine in the Marketplace

Patents on Triflupromazine

Experimental / Informatics

List of terms related to Triflupromazine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Triflupromazine (Vesprin) is an antipsychotic medication of the phenothiazine class. Among different effects of triflupromazine indication for use of this drug is severe emesis. Due to its potential side effects (triflupromazine has higher risk for side effects than many other antipsychotics) it is not gold standard in antiemetic therapy.

Serious side effects of trifluproamzine can be akathisia and tardive dyskinesia as well as the rare, but potentially fatal, neuroleptic malignant syndrome.

References


Linked-in.jpg